top of page

Carol Brosgart


Clinical Professor of Medicine, Biostatistics and Epidemiology at UCSF, an Independent Director on the Boards of public and privately held biotechnology companies

Dr. Brosgart received her B.S. in Community Medicine from the University of California, Berkeley (UCB), her M.D. from the University of California, San Francisco (UCSF), and her residency training in Pediatrics (UCSF) and Public Health and Preventive Medicine (UCB). She has published extensively in the areas of infectious diseases, focusing on antiviral therapy for HIV, HBV, CMV, and related public health policy.
She has served as a member of the United States Centers for Disease Control (CDC); Health and Human Services (HHS) Advisory Committee on HIV, Viral Hepatitis, and STD Prevention and Treatment; the U.S. Office of Minority Health HBV Stakeholders Task Force; Senior Advisor on Science and Policy to the Division of Viral Hepatitis at the CDC.

Dr. Brosgart was the Chief Medical Officer for Alios BioPharma (now Johnson & Johnson), Senior Vice President and Chief Medical Officer at UCSF Benioff Children’s Hospital & Research Center in Oakland, California. For eleven years Dr. Brosgart held several senior management positions at Gilead Sciences (Vice President, Clinical Research; Vice President, Medical Affairs; and Vice President, Public Health and Policy). While Vice President of Clinical Research at Gilead she was responsible for the clinical development and approval by the FDA and by regulatory authorities worldwide of two antiviral therapies: Viread® for the treatment of HIV, and Hepsera® for the treatment of Chronic Hepatitis B.

Dr. Brosgart is a member of the Boards of Directors of the Hepatitis B Foundation and the AP Giannini Foundation. She also serves on the Executive Committee of the Forum for Collaborative Research (FCR) at UC Berkeley and the steering committee of the HBV Cure Forum at the FCR. Previously, she has served on the Public Policy Committee of the American Association for the Study of Liver Disease (AASLD) and the National and Global Public Health Committee of the Infectious Diseases Society of America (IDSA).

She was among the first physicians in the United States to recognize and treat patients with HIV/AIDS. Dr. Brosgart was the founding Medical Director of the East Bay AIDS Center at Alta Bates Medical Center in Berkeley, California. She led NIH clinical trials as a member of the Community Programs for Clinical Research on AIDS (CPCRA), chaired the CPCRA Scientific Advisory Committee, and contributed to HIV antiretroviral drug development, and to the development of prophylactic and treatment agents for opportunistic and malignant complications of HIV/AIDS.

Carol Brosgart
bottom of page